Vogt U - Search Results

1

[Impact of DNA image cytometry (ICM) parameter and established prognostic factors on disease free survival (DFS) and overall survival (OS) of node-negative breast cancer (NNBC) patients].

Schlotter CM, Vogt U, Bosse U, Wassmann K. Schlotter CM, et al. Among authors: vogt u. Zentralbl Gynakol. 2003 Sep;125(9):368-74. doi: 10.1055/s-2003-43040. Zentralbl Gynakol. 2003. PMID: 14569519 German.

2

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.

Schlotter CM, Vogt U, Bosse U, Mersch B, Wassmann K. Schlotter CM, et al. Among authors: vogt u. Breast Cancer Res. 2003;5(2):R30-6. doi: 10.1186/bcr568. Epub 2003 Jan 13. Breast Cancer Res. 2003. PMID: 12631396 Free PMC article.

3

[Clinical importance of histology, grading and ploidies in primary breast cancer].

Schlotter CM, Kropp S, Wichert S, Vogt U, Krieg V, Bosse U, Wassmann K. Schlotter CM, et al. Among authors: vogt u. Zentralbl Gynakol. 1999;121(8):384-8. Zentralbl Gynakol. 1999. PMID: 10486881 German.

4

Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.

Schlotter CM, Tietze L, Vogt U, Heinsen CV, Hahn A. Schlotter CM, et al. Among authors: vogt u. Horm Mol Biol Clin Investig. 2017 Sep 22;32(2):/j/hmbci.2017.32.issue-2/hmbci-2017-0022/hmbci-2017-0022.xml. doi: 10.1515/hmbci-2017-0022. Horm Mol Biol Clin Investig. 2017. PMID: 28937963 Review.

5

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.

Brandt B, Vogt U, Schlotter CM, Jackisch C, Werkmeister R, Thomas M, von Eiff M, Bosse U, Assmann G, Zänker KS. Brandt B, et al. Among authors: vogt u. Gene. 1995 Jun 14;159(1):35-42. doi: 10.1016/0378-1119(94)00652-9. Gene. 1995. PMID: 7607571

6

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.

Vogt U, Bielawski K, Schlotter CM, Bosse U, Falkiewicz B, Podhajska AJ. Vogt U, et al. Gene. 1998 Nov 26;223(1-2):375-80. doi: 10.1016/s0378-1119(98)00454-5. Gene. 1998. PMID: 9858771

7

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

Vogt U, Bielawski KP, Bosse U, Schlotter CM. Vogt U, et al. Oncol Rep. 2004 Nov;12(5):1109-14. Oncol Rep. 2004. PMID: 15492801

8

Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay.

Vogt U, Falkiewicz B, Bielawski K, Bosse U, Schlotter CM. Vogt U, et al. Acta Biochim Pol. 2000;47(1):157-64. Acta Biochim Pol. 2000. PMID: 10961689

9

[Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?].

Granetzny A, Striehn E, Bosse U, Wagner W, Koch O, Vogt U, Froeschle P, Klinke F. Granetzny A, et al. Among authors: vogt u. Zentralbl Chir. 2003 Aug;128(8):640-4. doi: 10.1055/s-2003-41378. Zentralbl Chir. 2003. PMID: 12931258 German.

10

Molecular targeted therapies for breast cancer treatment.

Schlotter CM, Vogt U, Allgayer H, Brandt B. Schlotter CM, et al. Among authors: vogt u. Breast Cancer Res. 2008;10(4):211. doi: 10.1186/bcr2112. Epub 2008 Jul 24. Breast Cancer Res. 2008. PMID: 18671839 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters